Mergers and acquisitions happen all the time with companies; they’re simply a part of business. The pharmaceutical world has definitely seen its share of these buy-outs, and depending on your perspective, it can either be for the better or for the worse.
There were approximately $220 billion in pharmaceutical deals made during the first half of 2015, which was triple the amount during the first half of 2014, according to a recent report from consulting firm KPMG. But why such a rush for these companies to make such blockbuster deals?
Hey, check out all the research scientist jobs. Post your resume today!
